Sign in
Not yet recruitingNo phase

Mechanisms and Interventions of Treatment-Resistant Schizophrenia Based on Brain Organoids

Key facts

Who runs it
Shanghai Mental Health Center
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
10 people, planned
Starts
1 Jan 2027
Expected to end
31 Dec 2028
Type of study
Observational
Record updated
17 November 2026

Who can take part

Sex
Women and men

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Meet the DSM-5 diagnostic criteria for schizophrenia
  • Meets the diagnostic criteria for early-onset schizophrenia (age of onset < 18 years)
  • Meet the diagnostic criteria for treatment-resistant schizophrenia, defined as:; Inadequate response from adequate trials of two different classes of antipsychotic drugs (≥ 600 mg/day chlorpromazine equivalents), at least 6 weeks; Persistence of positive symptoms,defined as a score of ≥ 4 on at least two items, or a score of ≥ 6 on at least one item, of the positive subscale of the PANSS; At least moderate functional impairment, as indicated by a PSP score ≤ 70
  • Written informed consent

Who cannot take part

  • Current or past neurological illness, severe physical diseases, substance abuse or alcohol dependence, mental retardation, pregnant or lactation
  • Uncooperative or risky patients with high excitement, stupor, disorder of words and deeds, negative suicide, etc

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Approximately 20-30% of patients with schizophrenia show poor response to standard antipsychotic medications, which is defined as treatment- resistant schizophrenia (TRS), yet the underlying pathological mechanisms remain largely unknown. Brain organoids, also referred to as cerebral organoids, have emerged as a promising tool for modeling neurodevelopmental disorders in the laboratory. In this observational study, blood samples will be collected from TRS patients and their family members to generate personalized brain organoids. This study aims to elucidate the mechanisms of TRS and to provide preclinical evidence for developing personalized intervention strategies.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
17 November 2026